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 Autism spectrum disorder has been dramatically on the rise since the early 
1990s, with one in forty-five children being diagnosed in 2014.  It is known that 
contributing factors to autism spectrum disorder may have genetic and epigenetic origins, 
as well as environmental triggers.  What is still unclear, however, is the impact of 
teratogenic drugs, consumed by the mother, have on a developing fetus in utero.  How 
can they lead to the child developing autistic-like behaviors?  The current study 
documents the effects of one teratogenic drug Valproic acid, a known histone deacetylase 
inhibitor.  It establishes the role it plays on developing neurites and synapses within the 
brain.  This study supports Markram's proposal of an "intense world theory" 
characterized by autistic-like behaviors due to hyper-functioning microcircuits within the 
brain.  Dorsal root ganglia were dissected out of eight day old chick embryos, some of 
which were exposed to varying concentrations of Valproic Acid, to serve as a model for 
this study.  The dorsal root ganglia were cultured for 48 hours and then underwent a three 
day immunostaining procedure in order for their neurites and synapses to be observed 
clearly under the microscope.  Composite images of each dorsal root ganglia were 
constructed using the tiling program ImagePro Premier.  This program was also then 
used to count neurites and measure their lengths.  Another program ImageJ was used to 
measure the area of synaptogenesis.  Dorsal root ganglia exposed to Valproic Acid 
developed more and longer neurites when compared to controls.  When exposed to a 
specific concentration they began to develop larger synaptogenic areas.  These findings 
support Markram's "intense world theory" in demonstrating that in utero exposure to 
   
Valproic Acid may cause hyper-functioning synapses; begging to question as to whether 
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 Since the early 1990s there has been an evident increase in the number of 
children affected with autism spectrum disorder (ASD).  There are many factors that may 
contribute to this increase including, but not limited to, genetic, epigenetic, and 
environmental conditions.  Greater awareness and better diagnosis may explain some, but 
cannot explain the nearly exponential increase.  This study investigates the epigenetic 
effects by examining the teratogenic drug valproic acid and its impact on embryonic 
neurons in culture.  This approach should provide insight into one factor contributing to 
the etiology of autism at the cellular level. 
 
Literature Review 
Autism Spectrum Disorder 
 ASD can be defined as a complex developmental disability with symptoms 
typically appearing in early childhood that affects a person’s ability to communicate and 
interact with others (Autism Society 2016).  ASD has increased in prevalence among 
children, with cases jumping from one in two hundred-fifty reported in 2001 to one in 
forty-five in 2014 (Autism Speaks 2015).  This data leads to the question as to what is 
causing this dramatic increase in the number of children reported with ASD.  Certainly as 
technology and awareness of ASD advance, medical professionals are more apt to know 
the early signs and symptoms of ASD and are able to make improved diagnoses.  Yet it is 
improbable that this accounts for all of the increase.  Signs and symptoms of autism can 
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be divided into five categories: behavioral, developmental, cognitive, psychological, and 
other.  1) Behavioral signs include inappropriate social interaction, poor eye contact, 
compulsive behavior, impulsivity, repetitive movements, self-harm, and persistent 
repetition of words or actions.  2) Learning disabilities or speech delay are examples of 
developmental symptoms.  3) Intense interest in a limited number of things or problems 
paying attention fall under cognitive symptoms.  4) Psychological signs include 
unawareness of others' emotions or depression.  5) Other signs include but are not limited 
to anxiety, change in voice, excessive sensitivity to sound, or a tic (summarized from the 
CDC 2015).  There is no known single cause for autism, but evidence supports 
involvement of genetic and epigenetic factors.  This paper will focus on epigenetic 
factors that may lead to hypo- and hyper-connectivity of neurons in the developing brain. 
Valproic Acid  
 Valproic Acid (2-n-propyl pentanoic acid, VPA) is a medication primarily used 
to treat epilepsy and seizures, but also as an antipsychotic for bipolar disorder, and 
migraine treatment.  It may also be used to treat children with attention-deficit/hyper-
reactivity disorder (ADHD).  VPA has known teratogenic effects and has been linked to 
malformations in humans and other animals when exposed in utero, a configuration of 
symptoms known as fetal valproate syndrome (FVS) in humans (DiLiberti et al. 1984).  
FVS is reported as showing congenital malformations, dysmorphism and abnormal 
neurological signs at birth (Laegreid et al. 1993).  Larger studies have provided evidence 





risk of ASD, reporting the rate of ASD to be eight times larger in VPA treated mothers 
than the general population (Rasalam et al. 2005).   
The “Intense World Theory” 
The “intense world theory” of ASD can be described as excessive neuronal 
information processing and storage in the microcircuits of the brain that can produce 
hyper-perception, attention, and memory in those affected.  The cause of excessive 
processing may be attributed to hyper reactivity and plasticity of the microcircuits 
including hyper-connecting neighboring neurons producing excessive excitation as well 
as hyper-expressing N-methyl-D-aspartate (NMDA) receptors producing excessive 
plasticity in the neocortex.  The microcircuits may then become increasingly difficult to 
control and coordinate with other microcircuits when activated (summarized from 
Markram et al. 2007).  The hyper-functioning of microcircuits is expressed physically as 
it produces outward signs including decreased social interactions, excess sensitivity to 
pain, increased sensitivity to non-painful stimuli, repetitive activity, increased anxiety 
and high and longer fear memories that are harder to extinguish (Ebert and Greenberg 
2013).  These outward signs correlate with many of the symptoms of ASD.  
Rodent Model 
 Rodent models of ASD have frequently been used in research in order to exhibit 
the behavioral and neurological effects of prenatal VPA exposure.  In a study performed 
by Schneider and Przewlocki (2004) rats were exposed to VPA on the 12.5 day of 
gestation with offspring’s social behavior being examined in adulthood.  Their findings 
included a lower sensitivity to pain with higher sensitivity to non-painful stimuli, 
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diminished acoustic pre-pulsed inhibition, repetitive and lower exploratory activity, and a 
decreased number of social behaviors (Schneider and Prezwlocki 2004).  These behaviors 
can all be placed into one of the five categories listed above as typical signs and 
symptoms of ASD in children.   
Another study (Go et al. 2012) examined neuronal developmental effects of 
prenatal VPA exposure in rats.  One of their findings was induced macrocephaly with 
prenatal exposure to VPA.  This corroborates previous studies that found enlarged brain 
circumference in patients exhibiting ASD and FVS (Yoo et al. 2002).  Go and colleagues 
also reported an increase in the proliferation of neural progenitor cells (NPC) resulting in 
a delayed, but eventual increase in the number of differentiated neurons.  Affected 
cortical areas showed increased thickness, signifying that numbers of excitatory neurons 
may also be increased along with total number of neurons.  Increasing excitatory neurons 
with or without affecting (but leading to a down-regulation) inhibitory neurons would be 
enough to induce abnormal behavior such as repetitive and restricted behaviors, and also 
low pre-pulse inhibition, as mentioned above from the previous study of Schneider and 
Przewlocki (2004) (summarized from Go et al. 2012). 
Investigating further effects on neurons, Mi Ra Jeong and colleagues (2003) 
reported a study in which they harvested and cultured cortical neurons (CCN) from 17 
day old embryonic rats and treated them with 0.1-1 mM VPA starting at day 9 in vitro.  
CCNs not treated with VPA underwent spontaneous cell death with increasing age. 
However, VPA treated CCN’s spontaneous cell death was noticeably suppressed, 





fold increase of histone H3 acetylation, suggesting an inhibition of histone deacetylases 
(Jeong et al. 2003). 
Mechanism of Action 
 There is no single mechanism of action for VPA as it dissociates into valproate 
ions leading to multiple effects on neuronal tissue in the brain.  VPA increases brain 
concentrations of GABA (gamma-aminobutyric), an inhibitory neurotransmitter, which 
prevents seizures.  However, VPA is also thought to enhance the effects of pre-existing 
GABA on its receptors and on NMDA glutamate receptors, also contributing to its 
anticonvulsant effect (summarized from Smith 2015).  
Histone Deacetylase Inhibition 
 VPA is a known histone deacetylase (HDAC) inhibitor.  Histone deacetylases 
are important in regulating gene transcription and phenotype expression by functioning as 
transcriptional repressors.  HDACs have also been shown to act on many cellular 
substrates as well as on histones, demonstrating that acetylation may rival 
phosphorylation in importance (reviewed by Haberland et al. 2009).  HDACs can be 
separated into two classes: HDACI and HDACII.  MacDonald and Roskam (2008) 
observed that HDACI is expressed in neural stem cells/progenitors, but as they exit the 
cell cycle HDACI expression is lost. Expression of HDACI is however maintained in glia 
throughout the cell cycle.  HDACII is initiated in postmitotic neuroblasts and neurons, 
and upregulated as they commit to a neuronal lineage, but is not expressed in fully 
differentiated glia.  Studies have suggested that HDACI may contribute to fate decisions 
and lineage commitment and be a prominent player in deacetylation during glial 
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development.  On the other hand, HDACII may contribute to the regulation of subsets of 
neuronal genes during the differentiation of neurons (MacDonald and Roskam 2008).  A 
study done by Akhtar and colleagues (2009) used electrophysiological, 
immunocytochemical, and optical methods to demonstrate that HDACI- and HDACII- 
mediated chromatin silencing restricts the progression of excitatory synapse maturation 
during early synapse development.  They suggest that the chromatin state maintained by 
HDACs suppresses excitatory neurotransmission when synapse formation is sparse, but 
augments excitation when neuronal networks mature and synapses are in abundance 
(Akhtar et al. 2009).  Immature neural networks may have an enhanced vulnerability to 
HDAC inhibition leading to prominent increases in the structural assembly of synapses 
and growth of neural networks (Chomiak et al. 2013).  
 VPA accomplishes HDACI inhibition by binding to its catalytic site and 
blocking substrate access.  However it inhibits HDACII by inducing proteasomal 
degradation (Chomiak et al. 2013).  Phiel and colleagues (2001) also reported that VPA 
acts as a HDAC inhibitor.  They proposed that HDAC inhibition by VPA activates Wnt-
dependent gene expression that leads to increased expression of β-catenin and de-
repression of Tcf/Lef (group of transcription factors involved in the Wnt signaling 
pathway).  This can lead to the over-connectivity and hyper-excitability described in the 









 As is the case with histone deacetylation, histone methylation is an important 
epigenetic function for regulating gene transcription, developmental gene programs, and 
cellular phenotype (Chomiak et al. 2013).  Histone lysine methylation occurs on histones 
H3 and H4 and they can be mono-, di-, or tri-methylated.  Depending on the site of 
methylation it can signal either activation or repression.  It is speculated that methyl-H3-
K4 and methyl-H3-K9 are binding sites for proteins that mediate the biological effects of 
histone methylation modifications (Martin and Zhang 2005).  It is accepted that the tri-
methylation of histone H3-K4 is very important for transcriptional activation at promotor 
regions (Mosammaparast and Shi 2010), whereas methylation of H3-K9 may act to 
silence genes (Berger 2007).  
 In order to examine the effects of VPA on histone methylation and subsequent 
gene expression, Tung and Winn (2010) exposed pregnant mice to 400mg/kg VPA and 
collected their embryos at successive stages after injection with VPA.  They then 
examined the effects on histone methylation.  They observed a significant decrease in the 
expression of monomethyl histone H3-K9 and a significant increase in the expression of 
di- and tri-methylated histones H3-K4 suggesting a shift towards more active gene 
expression in the embryos (summarized from Tung and Winn 2010). 
 Rinaldi and colleagues (2007) exposed rat pups prenatally to VPA in order to 
investigate alterations made to the glutamatergic system and its second messenger 
pathways.  They found an overexpression of NMDA receptor subunits leading to 
enhanced NMDA receptor-mediated synaptic currents and amplified postsynaptic 
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plasticity in neocortical pyramidal neurons (Rinaldi et al. 2007).  NMDA receptors 
regulate the expression of brain-derived neurotrophic factor (BDNF).  An overexpression 
of NMDA receptors leads to an overexpression of BDNF, which in turn increases 
dendritic growth in neurons (Horch and Katz 2002). 
Dorsal Root Ganglia 
 Vertebrate embryos form a transient ectodermal structure known as the neural 
crest from which a subpopulation of migratory neural crest cells (NCCs) emerges.  An 
epithelial to mesenchyme transition (EMT) facilitates the migration of NCCs from the 
dorsal neural tube outward through the extracellular matrix towards remote target 
destinations where they differentiate into a wide array of diverse tissues.   
In one such differentiation, NCCs develop into the dorsal root ganglia (DRG).  
The NCCs that form DRGs migrate a short distance through anterior somite tissue and 
then settle segmentally in clusters to differentiate as bipolar neurons and glia.  As they 
continue to develop, DRGs send neural processes outwards to form junctions at target 
tissues and also inward medially to the spinal cord.  The DRGs contain the greatest 
proportion of sensory neurons that transmit information from the periphery into the 
central nervous system (Krames 2014) which can be explanted to tissue culture to create 
an experimental model of neural outgrowth (Cohen et al. 1954; Levi-Montalcini 1964; 
Letourneau 1975).  Once adhered in their target tissue a neural network forms and 
neurites begin to extend outward to form synaptic networks which can be detected by 
immunostaining with an SV2 antibody (Wiens et al. 2016).  A neurite is defined as any 





English Dictionary).  Growing axons then navigate through the cellular terrain and 
associated extracellular matrix to find appropriate synaptic partners.  They accomplish 
this through the use of growth cones, a specialized structure at the tip of growing axons, 
first discovered by Harrison (1910).  The morphology of a growth cone is a sheet-
expansion of the growing axon at its tip called a lamellapodium with many fine processes 
called filopodia that extend and retract to sense the environment and afford transient 
adhesion sites.  Growth cones explore the extracellular environment in order to determine 
the direction of growth and guide the axon’s extension in that direction (Purves et al. 
2001).  There are three important families of molecules that guide growth cones to their 
target destinations. The first, cell adhesion molecules, reside on cellular surfaces and 
extracellular matrix substrates along the path the growth cone is traveling and are 
recognized by specific receptors on the growth cone’s membrane.  Once contact has been 
made, other signals are transmitted to the cytoplasm and set the direction for growth cone 
adhesion and motility.  The second family contributing to growth cone guidance are 
diffusible molecules that guide the growth cone through chemotaxis by diffusing freely 
into the aqueous environment surrounding the growth cone.  They may either attract or 
repel the growth cones.  The third family consists of growth (trophic) factors that are also 
small diffusible molecules but act more generally to stimulate elongation of the axon and 







 Because VPA is known to mimic ASD in rodents by altering brain development 
via epigenetic dysregulation (Chomiak et al. 2013), it is important to examine its effects 
directly on the developmental cellular behavior of neurons. One suitable experimental 
system that can be used to examine this is DRG neurons in culture (Wiens et al. 2016).  
Therefore I have used immunostaining procedures and microscopic image analysis to 
investigate the neurites, growth cones, and neural networks of DRGs in eight-day-old 
chick embryos treated with increasing concentrations of VPA.  I have compared them to 
untreated controls.  As previous studies suggest, VPA should stimulate some or all 
neurogenic activities.  Therefore, I expect to find an increase in neurite number and 

















MATERIALS AND METHODS 
 
Dissection and Culture 
 Fertile chicken eggs were purchased from Mixdorf farms (Waterloo, IA) and 
incubated at 38˚C for eight days.  The method for dissection and culture of the DRGs by 
Wiens et al (2016) was followed.  On the eighth day embryos were extracted from the 
eggs and transferred to a petri dish containing Earle's Balanced Salt Solution (EBSS) 
(Sigma-Aldrich).  Each embryo was then placed into a sterile dish under a binocular 
microscope for dissection.  The head and internal organs were removed in order to 
expose the spinal cord.  Then, microscissors (Minitool, Inc., Los Gatos, CA) were used to 
sever the dorsal roots and excise the small, ovoid DRGs from their location near the 
spinal cord.  A micropipette was used to transfer them out of the dish into a second sterile 
dish of EBSS.  Twenty-five to thirty DRGs were typically collected from each embryo 
and the dish was then carefully transferred to a laminar flow hood to prepare the DRGs 
for culture.  Five to six DRGs were transferred via micropipette from the EBSS into 
Falcon Primaria 35 mm diameter culture dishes (Fisher Scientific) to ensure that two or 
more would attach.  Excess EBSS was removed and 2 mL of Medium 199 (Sigma-
Aldrich), supplemented with 10% fetal bovine serum (MP Biomedicals, Santa Ana, CA) 
and 1% antibiotic/antimycotic solution (CellnTec, Bern, Switzerland) was added to each 
dish.  Either 1, 2, 4, or 6 µL of VPA (2-propylpentanoic acid, Sigma-Aldrich) was added 
to the experimental dishes from a 2.0 M stock solution to achieve final concentrations of 
50, 100, 200, or 300 µM.  Control dishes received equivalent volumes of medium only.  
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The dishes were then incubated at 38 °C with 5% CO2 and 100% humidity for 36-48 
hours.  Attachment was observed by 24 hours for all conditions, and those explants not 
attached were excluded from the experiment. 
Fixation and Immunostaining 
 Following culture the DRGs were taken out of incubator and the dishes were 
immediately placed on ice in order to stop neural outgrowth and development.  The 
medium was then pipetted out and replaced with EBSS briefly to wash, and then 1 mL of 
ice cold 20% DMSO in methanol was pipetted into the dishes on ice for one hour with 
gentle agitation in order to fix the DRGs.  The method for the immunostaining of fixed 
DRGs was the method of Wiens et al (2016).  Briefly, after one hour of fixation, the 
cultures were washed with a phosphate buffer saline (PBS) solution three times for two 
minutes each.  A peroxidase quenching solution (3% H2O2 in methanol) was added to the 
dishes for ten minutes followed by 3 PBS washes.  The cultures were then permeabilized 
with gentle agitation for thirty minutes in 0.1% Triton X-100 in PBS followed by 3 more 
PBS washes.  Blocking solution (0.5% Tween-20, 2.5% bovine serum albumen, 0.5% 
nonfat dry milk in PBS) was then added for one hour with gentle agitation.  Mouse 
monoclonal antibody SV2 (Developmental Studies of Hybridoma Bank, University of 
Iowa Department of Biological Sciences, Iowa City, IA) secreted into culture solution 
was added to the blocking solution in a 1:20 dilution and incubated at 4°C overnight.  
The next day the cultures were warmed to ambient temperature with gentle agitation.  
The antibody-blocking solution mixture was removed and they were washed three times 





the dishes for 20 minutes followed by PBS washing three times and then streptavidin-
peroxidase conjugate solution, also from the kit, was added for 15 minutes with gentle 
agitation followed by PBS washing 3 times.  A chromagen mixture containing 1% 3-
amino-9-ethylcarbazole and 0.3% H2O2 in 0.05M acetate buffer was placed on the 
cultures and allowed to develop in darkness for 10 minutes after which antibody-positive 
DRGs were stained red.  This was then removed and the cultures immediately rinsed with 
dH2O to stop the reaction.  The stained cultures were then post-fixed in 3.7% 
paraformaldehyde solution at 4 °C for eight minutes to stabilize the red color.  The 
cultures were then rinsed and stored in the refrigerator in dH2O.  
 Seven control DRGs were also immunostained in the same way but without 
addition of the primary antibody.  Without adding primary antibody, the chromagen 
mixture could not adhere to synaptic vesicles and thus not stain red.  This showed that the 
immunostaining procedure was successful and that no non-specific binding occurred. 
Image Analysis in Image Pro Premier 
  Image composites and neurite and growth cone measurements were made using 
Image Pro Premier software (Media Cybernetics, Inc., Rockville, MD).  The culture dish 
was placed on the stage of a Leica DMIRE-2 inverted microscope with Q-Imaging CCD 
camera (Surrey, BC, Canada) attached and the DRG of interest was located and adjusted 
into focus using differential interference contrast optics on the screen of a Dell Optiplex 
980 computer.  Commands in the Image Pro Premier program were then used to tile the 
DRG with the 10x objective of the microscope in position until a composite image was 
created.   This was then saved as a .tiff image.  Image tiling refers to capturing multiple 
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images at an increased magnification and then aligning and joining them in order to 
create one composite image.  After the DRG images had been tiled and saved they were 
opened again in Image Pro Premier to count and measure neurites.  Before beginning the 
measurements the program was calibrated from pixels to micrometers using a section of 
ruler that had been tiled as before and setting the scale in the software.  A tiled image was 
then opened and twelve radial lines were drawn at successive 30° angles from the center 
of each explant (Figure 1).  Any neurite touching or crossing a line was counted and 
measured for length by using the mouse to trace it from where it began at its 
corresponding cell body or dendrite to where it ended at either another cell body or in the 
field of view.  This ensured a selection of a random representative sample.  The numbers 
given for length were then divided by two because the Image Pro program was increasing 
the number of pixels during tiling by overlapping the joined images.  This number was 
determined by comparing an uncalibrated tiled image to an image that was calibrated 
before and during tiling to compare pixels per unit.  Multiple explants were tested this 
way to give an average ratio of 0.5, thus dividing all initial measurements in half.  The 























Figure 1. Composite image of a DRG showing a dense neuronal network.  Random 
assessment was achieved by only counting and measuring neurites that touched or 
crossed any one of the twelve lines shown drawn at 30° angles from the center of the 
explant. (All markings shown as “PL” indicate neurites traced). 
 
 
Image Analysis in ImageJ 
 The red stained area of synaptogenesis was measured using the color 
thresholding feature in the program ImageJ.  First, the program was used to cut out the 
central DRG original explant (Figure 2).  This was necessary because of its 3-
dimensional complexity that made color thresholding inaccurate.  Furthermore, the aim 
was to assess synapse formation among neural connections that had been created during 
the period of culture, and these were peripheral.  There was a definite visible depth 
change among cells at the explants’ edge which was used to determine the border of the 
explant to cut out.  The color thresholding option of ImageJ was then used to find the 
total area of all the pixels above a computer-determined level of red intensity.  The total 
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area was then divided by two to account for the overlapped images created during tiling.  
It was also necessary to account for the variation in size of the explants.  A larger explant 
will have a larger synaptic area by default.  This was done by measuring the largest 
diameter of the cleared portion of each explant, finding the average of these, and dividing 
the average by each diameter.  This gave a diameter quotient that we used to adjust each 
peripheral area measured.  The corrected areas were lastly divided by their respective 
diameter quotient to end with our area of synaptogenesis in square microns used for 






Figure 2. Composite images of cultured DRGs in ImageJ program. A) Control DRG with 
the central DRG cut out to measure synaptogenic area around peripheral edges. B) DRG 
exposed to 100µM concentration of VPA with the central DRG cut out to measure 








 The raw measurements for the neurites were initially saved in Excel files and 
then sorted and saved as CSV files for further analysis.  R language for statistical 
computing (R Core Team, 2012) was used to create histograms and boxplots of the data.  
Significance values for neurite length and synaptogenic area were p ≤ 0.05 and were 
computed in R using the Wilcoxon Rank Sum Test because the histogram data analysis 
showed the values were not normally distributed.  Histogram data for neurite number 
showed normally distributed values, so significance was computed using a T-TEST in 


















 In this study, I carried out experiments in order to observe if there was evidence 
that the pharmaceutical valproic acid may cause increased neuronal outgrowth, thus 
leading to an increased risk for the development of ASD.  The DRGs of eight-day-old 
chick embryos were used as my model for analysis.  DRGs develop along the spinal cord 
in both chicks and humans, as part of the peripheral nervous system, and feature neurons 
that extend neurites led by growth cones during their development.  The growth cones 
eventually establish synaptic connections both with receptors peripherally and also within 
the developing spinal cord.  Immunostaining and image analysis techniques were used to 
evaluate both unexposed (control) DRGs and DRGs exposed to varying concentrations of 
VPA.  At the time of dissection, the DRGs are lined up along the spinal cord, ready to 
innervate target tissues.  In culture, they adhere to the treated, charged plastic culture dish 
and spread outward.  Monoclonal antibody SV2 was used to detect and measure the 
extent of differentiating synaptic networks.   
Developmental Progression and Staining Specificity 
 The DRGs attached to the culture dish within a few hours.  This was 
accompanied by the appearance of early migrating fibroblasts at the peripheral edges.  
Following these cells and mainly using them as a migration substrate, neurons with thick 
cell bodies (recognizable by their phase halos) and neuronal processes (neurites) began to 
extend outward in all directions.  Their neuronal processes lengthened, led by growth 





culture, the neurites began to assemble into “nerves” that were thicker than neurites, and 
consisted of multiple neurites in bundles. 
 Immunostaining was performed using both primary and secondary antibodies in 
order to locate the development of synaptic networks around the explants.  Synaptic 
networks stained red indicating the presence of neuronal structures having synaptic 
vesicles (Figure 3, B and C).  This included cell bodies, neurites and growth cones as 
well as maturing synapses, as these areas contained differentiating components of 
synaptic vesicles (Figure 3, D).  In order to exclude non-specific binding of the antibody, 
nine explants were taken through all steps of the immunostaining procedure, but were not 
exposed to the primary mouse monoclonal SV2 antibody.  The secondary anti-mouse 
biotinylated antibody binds to the primary, so without it no red color should be observed.  
In our case, no red color was observed, indicating little or no non-specific binding of the 














Figure 3.  Composite images of cultured DRG explants after 48 hr. of culture.  The 
original DRG lies elevated somewhat at the center of a spreading layer of cells.  
Elongated neural processes (neurites) are indicated by arrows. A) A no primary antibody 
control showing no red stained areas. B) An immunostained control DRG showing its 
neuronal network. C) An immunostained DRG exposed to 100µM VPA concentration, 
showing a more extensive neuronal network.  D) Enlarged area shown inside the box of C 
showing matured synapses with clear cell bodies and neurites that had developed during 







The Effect of Valproic Acid on the Number of Neurites 
 The DRGs transferred to Primaria culture dishes attached to the dish surface 
within the first day of culture and a neuronal network began to grow outward in all 
directions from the explant.  Explants were removed from culture after 48 hours and 
immunostained as described above.  Image analysis was performed to examine the 
neuronal networks.  Noticeable among them were very thin, straight cell processes that 
could be traced back to a larger cell body (neuron) and we identified these as neurites 
(Figure 3, D).  All statistical data accumulated is based on the averages of all neurites 
counted for number and measured for length and area for each respective experiment.  
The number of DRGs collected and analyzed for neurite number and length was 31 
control DRGs, 8 50 µM VPA DRGs, 36 for 100 µM VPA DRGs, 10 for 200 µM VPA 
DRGs, and 9 for 300 µM VPA DRGs.  The average number of neurites per DRG for each 
group is shown in Figure 4.  The complete data set is given in Table B1, Appendix B.  A 
histogram plot of this data showed a normal distribution (Appendix A, A1).  Therefore, a 
T-TEST was used to determine whether differences were significant.  All of the treated 
explants, except those treated with 50 µM VPA, showed a significantly larger number of 
neurites than controls.  However, the treated explants did not differ significantly from one 
other.  All significance values can be seen in Table C1, Appendix C.   








Figure 4. Average number of neurites ± standard deviation found in each 12-line random 
sample taken from the indicated number of DRG explants.  Treatment with VPA resulted 
in a greater number of neurites per explant.  Error bars show standard deviation.  














The Effect of Valproic Acid on Neurite Length 
 As described above, neurites were counted based on whether they touched or 
crossed one of the twelve sample lines (Figure 1).  Once each such neurite was located, 
its length was measured from where it began at the cell body to where it ended at a 
corresponding cell body or in the field of view.  These were traced using a computer 
mouse and length measurements were generated by the Image Pro Premier software in 
microns after calibration had been applied.  After all analysis was completed, the 
measurements generated by the software were each divided in half to make up for the 
extra pixels created during tiling.  The average length of neurites per DRG was 54 µm for 
the control, 71 µm for 50 µM VPA, 112 µm for 100 µM VPA, 74 µm for 200 µM VPA, 
and 71 µm for 300 µM VPA.  The complete data set is given in Table B2, Appendix B.  
A histogram was created for the data set which showed a non-normal distribution (see 
Appendix A, A2).  This is because the outgrowth of the explants neuronal networks was 
radial, therefore there were many more, shorter neurites closer to the edge of the explant.  
Thus, lengths tapered oppositely and rapidly with distance from the edge, and these 
taperings led to the non-normal distribution (Wiens et al. 2016).  Since the data was not 
normal, the Wilcoxon Rank Sum Test was used to analyze significance as it accounts for 
the non-normally distributed data.  The Wilcoxon test showed many significant 
differences, most prominently that all treated explants developed neurites that were 
significantly greater in length than controls.  When compared to each other, neurites from 
explants treated with 100 µM VPA were significantly longer than those from explants 
treated with 50 µM, 200 µM or 300 µM VPA.  Unexpectedly, explants treated with either 
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200 µM or 300 µM VPA were not significantly longer than those treated with 50 µM 
VPA and there was no significant difference in length between those treated with 200 µM 
and 300 µM VPA (see Table C2, Appendix C for all significance values).  Figure 5 







































































Figure 5. Boxplot of data depicting lengths of neurites collected from a random sample 
around explants.  Treatment with VPA resulted in neurites with greater lengths when 
compared to untreated explants with a maximum effect with 100 µM VPA.  A boxplot of 
the data is seen here.  Boxes represent data measured from 31, 8, 36, 10, and 9 explants 
respectively.  The heavy black lines represent median lengths, lower end of the boxes 
represent first quartiles, upper end of boxes represent third quartiles, and whisker’s show 
maxima and minima neurite lengths.  Significance analysis showed all lengths being 
significantly greater than those of control explants and are represented as p ≤ 0.05 with an 
asterisk.  The concentration at 100 µM has significance indicated with a double asterisk, 
for neurite length at that concentration was significantly greater when compared to 





The Effect of Valproic Acid on the Area of Synaptogenesis 
 
 Area of synaptogenesis around the DRG was also analyzed.  It was expected to 
increase among those explants treated with VPA.  The SV2 antibody used during the 
immunostaining procedure specifically binds to synaptic vesicles and their precursor 
molecular components assembled in neurons around the DRG.  The middle of the explant 
was clearly and prominently stained red due to a very high concentration of synaptic 
vesicles in that area.  However, because of the high density and three-dimensional 
arrangement of neurons there, staining was difficult to evaluate accurately.  Also, our aim 
was to assess the synapses formed during culture, therefore, we restricted analysis to the 
circumference of the explant.  Before beginning analysis we carefully traced a border 
around the body of the explant.  The border was drawn around those cells which had not 
migrated outward and this could be seen as a noticeable depth change of the cells (Figure 
2).  Area measurements were then generated in square microns by ImageJ Software with 
corrections for pixels and DRG shape accounted for as described in Methods.  10 control 
DRGs, 8 50 µM VPA DRGs, 10 100 µM VPA DRGs, 10 200 µM VPA DRGs, and 9 300 
µM VPA DRGS were measured for their amount of red-stained synaptogenic area.  The 
average stained area of explants was 8113 µm2 for the control, 10641 µm2 for 50 µM 
VPA, 12119 µm2 for 100 µM VPA, 10040 µm2 for 200 µM VPA, and 13148 µm2 for 300 
µM VPA.  A complete data set is shown in Table B3, Appendix B.  A histogram was 
created for the data set and showed non-normal distribution (see Appendix A, A3), so the 
Wilcoxon Rank Sum Test was used to test for significance.  Explants treated with 300 





comparisons were not found to be significantly different (see Table C3, Appendix C for 
































Figure 6. Boxplot of the data depicting area of synaptogenesis in square microns of area 
around the explants.  Treatment with VPA resulted in larger synaptogenic areas around 
the explant when compared to untreated DRGs.  Boxes represent data measured from 10 
controls, 8 50 µM VPA, 10 100 µM VPA, 10 200 µM VPA, and 10 300 µM VPA DRGs.  
Treatment with 300 µM VPA resulted in a significantly larger area of synaptogenesis 
with p ≤ 0.05 and is shown with an asterisk.  Thick black lines represent median, bottom 
portion represents first quartile, top portion represents third quartile, and whiskers 







 Valproic acid is a pharmaceutical primarily used to treat seizures due to its 
strong anti-epileptic properties that involve reducing neuronal activity by blocking 
sodium and calcium channels and by enhancing the function of GABA, an inhibitory 
neurotransmitter.  However, maternal ingestion of VPA during pregnancy may have 
profound teratogenic effects on the developing fetus which are associated with a 3-fold 
increase in the rate of major malformations (Kataoka et al. 2013).  Also, VPA ingestion 
while pregnant may lead to an increased risk of development of autism-like behaviors in 
children.  This occurs mainly because of increased histone acetylation leading to hyper-
connected neural networks in the brain.  In this study, I modeled neurogenesis using DRG 
explants from eight day old chick embryos and exposing them to increasing 
concentrations of VPA.  This allowed for the examination of neurons at the cellular level 
including the formation of neurites led by growth cones and neural network formation.  
At day six of incubation neurons of DRGs in the chick embryo initiate neurites to 
innervate the spinal cord and connect to peripheral receptors.  Therefore neurogenesis 
begins and accelerates at a time when the same neurogenic events are underway in the 
brain and spinal cord.  At day eight of incubation, DRGs can be easily dissected from the 
spinal cord and cultured.   
My results demonstrated that DRGs exposed to VPA initiated more neurites that 
were longer when compared to control.  This enabled the development of larger neural 





hyper-excitable neural networks in a developing fetus leading to an “intense world” 
characterized by autistic-like behaviors (Markram et al. 2007). 
My dose-dependent findings showed a maximum effect on neurite length and 
number for those DRGs treated with 100 µM VPA.  There are a couple of reasons as to 
why this could have happened.  There were 36 DRGs that were exposed to 100 µM VPA, 
whereas there were only 10 DRGs exposed to 200 µM VPA and 9 DRGs exposed to 300 
µM VPA, therefore the data could be slightly off.  Another possible reason for this could 
be that at exposure to 100 µM VPA activates complete histone deacetylase inhibition and 
displays its maximum effect.  When the DRGs were exposed to 200 µM and 300 µM the 
increase in neurite number and length was still significantly higher than controls, but not 
100 µM concentration.  This could also be due to VPA inducing a saturable effect, where 
increasing concentrations of the chemical do not continue to increase neurite number and 
length.  The effect for number and length seem to level off at 100 µM, but the area of 
synaptogenesis data continues to rise with a maximum and significant effect at 300 µM 
VPA.  The biological processes measured were different ones therefore it is possible that 
neurite number and length have a maximum response at 100 µM, but the synaptogenic 
area will continue to increase with increasing concentrations of VPA.  In order to resolve 
what is happening here, further research should be executed.     
  The activity of histone deacetylases is an important factor in the regulation of 
genes associated with chromatin condensation.  It has been shown that HDAC1 is 
required to switch neural progenitor cells (NPC) from proliferation to differentiation in 
the developing vertebrate retina, and a mutant model of HDAC1 failed to do so therefore 
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proliferation of NPCs was increased (Go et al. 2012).  By inhibiting the epigenetic 
activity of histone deacetylases a group of genes may be turned on that would result in 
the increased number of neurites found in this experiment.  One such mechanism is the 
selective overexpression of the ionotropic NMDA receptor subunits NR2A and NR2B.  
Rinaldi and colleagues (2007) performed a study in 2002 that involved prenatally 
exposing rats to VPA and monitoring the changes in glutamate mediated synaptic 
transmission and plasticity in the neocortex.  They found that ionotropic NMDA 
receptors are the key receptors underlying synaptic plasticity in the neocortex, so their 
data suggests that an important aspect in VPA exposure is related to synaptic plasticity.  
These authors also reported that Calcium/Calmodulin-dependent protein kinase II 
(CAMKII) is the second messenger most closely linked to ionotropic NMDA receptors, 
and was also found to be overexpressed in VPA treated rats.  CAMKII mediates synaptic 
plasticity, experience-dependent synaptic changes and memory.  CAMKII also mediates 
the postsynaptic form of long-term potentiation or LTP (an increase in synaptic strength 
following stimulation of a chemical synapse) and has also been found to be enhanced in 
VPA treated rats.  The overexpression of these receptors translates into enhanced NMDA 
receptor-mediated synaptic currents and an amplified postsynaptic form of synaptic 
plasticity in the neocortex.  Their results suggest molecular and synaptic alterations in 
children prenatally exposed to VPA (Rinaldi et al. 2007).  My findings showed an 
increase in average neurite number, length, and in synaptogenic area.  This leads us to 
believe that HDAC inhibition is a leading mechanism of action in the neural networks of 





It has also been shown that enhanced activity of the NR2A subunit can lead to 
increased brain-derived neurotropic factor (BDNF) expression, which is important in 
neuronal development as it has been shown to increase the number of basal dendrites 
(Horch and Katz 2002).  A study done by Yoo and colleagues (2016) looked at effects of 
increased expression of BDNF on neurogenesis in mouse brains.  They found increased 
neurogenesis and neurite outgrowth during the early developmental stages of mice with 
an overexpression of BDNF (Yoo et al. 2002).  Our results showing the increased neurite 
number, length and area in VPA exposed DRGs are consistent with Yoo's findings, 
indicating a possible mechanism by which this is happening.  Yoo and colleagues (2002) 
also found an increased brain size in mice exhibiting BDNF overexpression, which was 
correlated with ASD in its early years of study.  In an earlier study published by 
Kimpinski and colleagues (1997) a different neurotropin, nerve growth factor (NGF), was 
shown to stimulate an increase in the elongation of distal neurites in both neonatal and 
adult sensory neurons (Kimpinski et al. 1997).  This leads us to believe that HDAC is 
switching on groups of neurotropin genes that could lead to longer neurites and a greater 
neural area.   
Another possible mechanism leading to the increased neural network is VPA’s 
ability to regulate the GSK3 pathway.  VPA has been shown to prolong NPC 
proliferation through phosphorylation of GSK-3β (Go et al. 2012).  The GSK3 pathway is 
also regulated by BDNF and the NMDA receptor.  As described above, exposure to VPA 
leads to overexpression of both BDNF and the NMDA receptor (Rinaldi et al. 2007; Yoo 
et al. 2002).   
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VPA may also regulate Wnt expression by regulating chromatin methylation.  
Prenatal exposure to VPA causes demethylation in the promotor regions of Wnt1 and 
Wnt2 which increases mRNA and protein levels in the cortical regions of offspring.  This 
leads to increased levels of β-catenin which, as discussed, can affect the GSK3 pathway 
and neurogenesis (Go et al. 2012).  The findings of this study support all the mechanisms, 
described above, that lead to increased neurogenesis and neurite outgrowth from 
exposure to VPA.  These findings also support the hypothesis that VPA, as an HDAC 
inhibitor, leads to neurons in the cortical areas of the brain to become hyper-excitable.  
These findings may also bring into question as to whether other pharmaceuticals that act 
as HDAC inhibitors could have the same effects on a developing fetus when exposed in 
utero.  Overall, our results and those of others align with the theory of an “intense world” 
(Markram et al. 2007) in which hyper-functioning microcircuits in the brain regulate 
many physical and behavioral characteristic of ASD in children. 
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COMPLETE DATA SETS 
 
Table B1. Average, median, minimum, and maximum DRG neurite number.  Numbers 













Table B2. Average, median, minimum, and maximum DRG neurite length.  Numbers 
listed are a representation of total averages. 
 
 
 Average  Median  Minimum  Maximum  
Control 
 
16.09667 15 7 29 
50 µM 
 
22.75 22.5 10 36 
100 µM 
 
25.83333 25 12 42 
200 µM 
 
24.9 23.5 13 35 
300 µM 
 
22.66667 23 10 30 




53.98859 49.747 38.68414 83.4627 
50 µM 
 
70.57807 64.66285 50.23535 102.0684 
100 µM 
 
111.802 108.2713 50.33595 193.2348 
200 µM 
 
74.08639 71.08172 47.17987 98.751 
300 µM 
 





Table B3. Average, median, minimum, and maximum DRG synaptogenic area.  Numbers 

















 Average (µm)  Median (µm) Minimum (µm) Maximum 
(µm) 
Control  8112.56701 5773.16737 622.059195 26005.6752 
50 µM 10641.0942 8651.62218 2723.09832 26768.0041 
100 µM 12118.7537 5988.66905 2942.61006 37535.6902 
200 µM 10039.9141 7361.0218 2322.1984 22191.9767 




SIGNIFICANCE TESTING DATA SETS 
Table C1. Significance values as determined by the T-TEST for neurite number.  Each 
treated explant compared to the control and to each other.  Bolded values indicate 











Table C2. Significance values as determined by the Wilcoxon Rank Sum Test for neurite 
length.  Each treated explant compared to the control and to each other.  Bolded values 










 50 µM 100 µM 200 µM 300 µM 
Control 
 
0.065764 2.73536^-7 0.002113 0.010594 
50 µM 
 
 0.373373 0.567203 0.981834 
100 µM 
 
  0.715126 0.205093 
200 µM 
 
   0.44674 
 50 µM 100 µM 200 µM 300 µM 
Control 0.005272 8.636 × 10-14 .0005786 0.001416 
50 µM  0.0008243 0.4598 0.9626 
100 µM   0.001064 0.0002873 





C3. Significance values as determined by the Wilcoxon Rank Sum Test for synaptogenic 
area.  Each treated explant compared to the control and to each other.  Bolded values 
indicate significance with p ≤ 0.05. 
 
 
 50 µM 100 µM 200 µM 300 µM 
Control 0.1728 0.2799 0.4262 0.04347 
50 µM  0.8286 0.7168 0.3704 
100 µM   0.8633 0.2775 
200 µM    0.2947 
